Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis

OBJECTIVE: Treatments for enthesitis-related arthritis (ERA) consist of a mono- or combination therapy with non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs (DMARDs), and biological agents, and they are primarily based on adult studies and studies on other forms of juven...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Rheumatol
Päätekijät: Kısaarslan, Ayşenur Paç, Sözeri, Betül, Gündüz, Zübeyde, Zararsız, Gökmen, Poyrazoğlu, Hakan, Düşünsel, Ruhan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Medical Research and Education Association 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668635/
https://ncbi.nlm.nih.gov/pubmed/31070580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2019.18180
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia